https://www.axios.com/2026/11/08/nvidia-ceo-jensen-huang-affair-email-to-company

😮‍💨

When China first allowed banks to package and sell nonperforming consumer loans in 2021, just 18.6 billion yuan ($2.8 billion) was transferred off banks’ balance sheets and sold to distressed-asset managers by the end of that year. By the close of 2025, that figure had surged more than 20 times, to about 454 billion yuan, according to Ruiunion Credit Platform, a Shenzhen-based company which provides asset valuations.
“This isn’t a story about reckless borrowing,” says Huang Yuying, 32, the manager of a midsize debt-collection company in the eastern city of Hefei. “More often it’s because of failed businesses, job losses or sharp drops in income.”
As many as 100 million Chinese consumers are struggling to service personal debt, according to Bloomberg Businessweek estimates based on research by Gavekal Dragonomics. The debt overhang is weighing on an economy already grappling with weak consumer confidence and sluggish growth, with households channeling more of their income toward repayments and banks becoming increasingly cautious about extending fresh credit.
The situation deteriorated further this year, after China tightened oversight of consumer loans issued through online platforms. Regulators told such lenders to keep average interest rates on new loans below 20%, people familiar with the matter have said. That reduced the credit available to borrowers who’d been using loans from multiple platforms to pay down other loans.
Toxic personal debt has swelled so much that some banks are now trying to off-load them every month rather than once a quarter as in the past, according to managers familiar with the matter, who asked not to be identified because the information is private.

In typical transactions, distressed-debt firms will pay 6% to 7% of the outstanding loan balance, and managers can extract about 30% of what a borrower owes. That leaves substantial room for profit — if people pay up.
That’s where Huang, the debt-collection manager, enters the picture. Every percentage point promised in an investor presentation ultimately comes down to someone picking up the phone and persuading a stranger to repay. The job is difficult and emotionally draining. Few people list “debt collection” as their dream job. For Huang, it was a last resort. A programmer at an auto‑financing startup, he saw his employer collapse during the pandemic as overdue loans surged. “I took one look and thought: There’s an industry with a future. So I switched careers and became a debt collector,” he says.
Each month usually begins with a fresh batch of delinquent borrowers. Huang and his colleagues review spreadsheets containing thousands of overdue accounts, sorting cases by how likely they are to be repaid. Borrowers prone to answering the phone are flagged. WeChat profiles are tracked down. Emergency contacts, guarantors and family members are mapped out, helping collectors piece together who might still have the means — and the willingness — to pay.

Wallahi we are finished

$CVS- They just announced they're breaking themselves up, but their retail pharmacy business is rotten and as a stand alone stock there will be nothing, but short sellers circling the waters.

Background: CVS Health Corp is breaking itself up into two separate companies after 8 years of being a combined company with a PBM, CVS Caremark, Health Insurer (Aetna), retail CVS Pharmacies, CVS Specialty, etc. The retail business will be separated to stop anti trust lawsuits, regulators and traded as it's own company.

That said, anyone familiar with CVS retail stores knows they have gigantic losses from theft/shrink nationwide, few stores have loss prevention or security, and their retail stores are ghost towns with the exception of the pharmacy where prescriptions/scripts are filled and Minute Clinics. The other huge negative is their prices on over 90% of items is a rip off, double to triple what Walgreens, Target, Walm, Dollar General, Dollar Tree costs. Even their generic branded products are more expensive than many name brands at other retailers.

Shareholders who currently own stock will get shares in both companies, but the new retail company shares should be sold ASAP! Does anyone believe the spunoff retail company will be viable or just go the route of another failed pharmacy chain- Rite Aid?

Everything you need to know is in the title. Anything beyond that costs extra.

In the last 2 trading sessions, SMCI seemed to have outperformed Dell by falling less and recovering more.

Reasons why it is SMCI's turn to outperform vs.

Dell:

- It fell much more and is close to its lows

- Much lower valuation

- Pure play on Al with stronger growth

- Turning around with new CFO, margins and profitability, better working capital management, less leveraged etc

- Supports SPCX strong growth as articulated by Elon Musk over the weekend

Additional reasons why Dell should underperform SMCI

- Exposed to PC business, which is a challenged segment (based on Intel)

- Trump pump effect over, post the midterms

Anything else?

Went from full porting shares 150 -> 300k. Then my dumb ass enabled options trading. It’s fucking over.

Just a handful of photos showing that the majority of the wall-streets’ proclaimed “dead retail stocks” of last year that make up the “bottom cap companies” of the S&P 500 & Nasdaq now are all practically up 100%+ and more for the year.

Ironically, these “bottom companies” outperformed almost every other mainstream blue-blood tech and retail company the news covered instead this year.